FDA Approves New Weight Loss Drug, Belviq

The Food and Drug Administration has approved a new weight loss drug, the first in the U.S. market in over 13 years.  The last weight loss drug, Orlistat (or generically Xenical), was approved in 1999 and worked by preventing the absorption of fats from the diet. On Wednesday the FDA approved the anti-obesity drug, Belviq (or generically lorcaserin).  Arena Pharmaceuticals attempted to have the drug approved in 2010, but scientists found tumors in animals taking the drug.  After some additional data was resubmitted, clinical studies in humans found the drug to be safe with no concern of tumors.  Typical side effects include depression, migraines, and memory lapses. It is expected to hit the market some time next year.

The FDA has approved the drug, Belviq, for weight loss. It is expected to hit the market in 2013. It is the first weight loss drug to be approved in the U.S. in over a decade.

With nearly 2/3 of the U.S. population being overweight or obese, the obesity epidemic in this country is staggering.  The drug allows doctors to prescribe a drug marketed for obese individuals (BMI of 30 or above) or overweight individuals (BMI of 27 or higher) who also present at least one comorbid condition related to obesity (such as type 2 diabetes, high blood pressure, or high cholesterol).  It is not meant to be used alone, however.  Patients should use the drug to supplement a healthy diet, regular exercise, and an active lifestyle.  Arena Pharmaceutical performed three randomized-control clinical trials consisting of over 8,000 participants  (diabetic and non-diabetic) lasting over 1-2 years.  Belviq showed moderate weight loss.  Patients lost an average of 3-3.7% of their starting weight over the course of a year.  Nearly 47% of diabetic patients lost an average of 5% of their starting weight, making it an effective weight loss tool for the FDA’s standards.  However, if individuals don’t see any significant weight loss in the first three months, it is unlikely that they will have beneficial results by continuing to stay on the drug.  The company is required by the FDA to conduct six more postmarketing studies to assess the drugs cardiovascular safety and the risk of stroke and heart attack.

How does the drug work?  The drug works by altering chemical signals in the brain that control appetite and hunger.  Belviq triggers the receptors for the neurotransmitter, Serotonin, which triggers feelings of fullness and satiety.  Taking Belviq can make a person feel fuller after eating smaller amounts of food, leading to a calorie deficit and eventual weight loss.  The drug works similar to the biochemical process that makes anti-depressants so effective – they prevent the reuptake of specific neurotransmitters.

Are weight loss drugs the answer to America’s obesity problems? Absolutely not. Unfortunately, however, this is the mentality of many people who are prescribed a weight loss drug.  Patients believe that this “magic pill” will suddenly melt the fat off their body and they can continue to eat and do whatever they want without putting in any work.  Therefore, the public needs to be educated on how to properly manage their weight with proper diet and exercise…and this is where dietitians come in! I also think diet pills can be beneficial for people who have been “yo-yo” dieting their whole life.  Individuals will try to lose weight for a short amount of time, and when they don’t see the results they want, they give up and go back to their old habits.  By “failing” at their weight loss goals, the lose their confidence in their ability to shed the pounds.  I think this is where anti-obesity drugs can be the most effective.  For people who have lost their confidence, a drug may spark some weight loss.  When patients see such positive results, they will begin to gain back the self-efficacy needed to maintain sufficient weight loss.  Eventually (and hopefully) people will learn to wean off the drug and be able to maintain their weight on their own…not to mention properly manage comorbid conditions like diabetes, hypercholesterolemia, and high blood pressure.

For more information on Belviq, check out the FDA report at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm309993.htm.


4 thoughts on “FDA Approves New Weight Loss Drug, Belviq

  1. Interesting….So if patients lost an average of 3-3.7% of their starting weight over the course of a year, that means that a 300 pound man lost 10-11 pounds in the course of a year. That’s a difference of about eating 105 calories less a day, presumably through the use of the pill. If someone was 250 pounds, they would’ve lost around 8.25-9.25 pounds in one year. That equates to eating 89 less calories each day. I mean, that’s not a lot at all. Obese and overweight individuals can be losing 1/2-2 pounds each week, safely, through moderate diet and exercise. A pill makes you feel fuller, but only full enough to cut back on a mere 89-105 calories a day might not be enough of a draw for some people. I guess it depends a lot on the cost of the pills. If they are relatively cheap, perhaps some individuals will think its worth a 3.3-3.7% weight loss in a year. Maybe others will think that the price is not worth the 8-11 pounds they might lose. It’s interesting! I wonder how well they monitored/recorded the study participants’ diet & exercise habits to see how closely they were following the recomendation. I feel as though if indivuals on Belviq were indeed using the drug to supplement a “healthy diet, regular exercise, and an active lifestyle they’d lose more than 3.5% of their body weight in a year.

  2. This is the right blog for anyone who wants to find out about this topic. You realize so much its almost hard to argue with you (not that I actually would want…HaHa). You definitely put a new spin on a topic thats been written about for years. Great stuff, just great!

  3. I’m impressed, I must say. Really rarely do I encounter a blog that’s both educative and entertaining, and let me tell you, you have hit the nail on the head. Your idea is outstanding; the issue is something that not enough people are speaking intelligently about. I am very happy that I stumbled across this in my search for something relating to this.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s